Invesco Dynamic Pharmaceuticals ETF Price & Performance (PJP)

Outset Medical, Inc. has completed a 1-for-15 reverse stock split, consolidating its shares. Shareholders now hold one share for every 15 previously owned, with fractional shares being retained. This corporate action aims to adjust the stock's market value and improve its trading dynamics.1

CNS Pharmaceuticals' stock has plummeted nearly 99.61% over the past year, with a current price of $3.62. The company has seen significant volatility, with a 52-week high of $975 and low of $2. Investors remain cautious amid ongoing challenges.2

Invesco Pharmaceuticals ETF (PJP) experienced a slight increase of 0.3%, opening at $84.11. The ETF tracks pharmaceutical industry performance, focusing on growth and valuation metrics. Its market cap stands at $254.85 million, with a 12-month high of $89.87.3